Phage therapy for environmental biotechnology applications
Frontiers in Microbiology · 03.09.2025 · 16
DOI: 10.3389/fmicb.2025.1621103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 03.09.2025. Verfasst von Suniti Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cranfield University, Bedfordshire, United Kingdom. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Environmental compartments, from soils and crop rhizospheres, to bio-reactors and municipal water networks have emerged as dynamic hot-spots for antimicrobial-resistance evolution and dissemination. Bacteriophages offer a precision, self-amplifying alternative to conventional biocides, yet their environmental deployment, intellectual-property space and commercial readiness remain only partially charted. Here, we critically synthesize the past decade of progress in phage-based interventions across three sectors: (i) soil remediation and crop-protection interfaces, where multi-phage cocktails suppress wilt- and blight-causing pathogens while preserving beneficial microbiota; (ii) biofuel and petro-energy infrastructures, in which lytic phages mitigate the microbiologically influenced corrosion and contaminated fermentations, restoring ethanol yields; and (iii) natural and engineered water systems, where phages show promise in treating recalcitrant biofilms, algal blooms and selectively ablate World Health Organization-priority pathogens. Meta-analysis of the World Intellectual Property Organization database reveals rapidly rising but geographically skewed patent activity, with China and the United States accounting for >61% of reviewed filings, and a gap between laboratory proof-of-concepts and marketed products. We identify bottlenecks, including lack of good manufacturing practice at scale, fragmented regulatory frameworks, and the evolutionary balance between single-phage precision and cocktail breadth. A roadmap is suggested that couples high-throughput phage discovery, synthetic tailoring and adaptive approval pathways. Together, these advances position environmental phage therapy to become a cornerstone of the One-Health response to increasing levels of microbial resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cranfield University, Bedfordshire, United Kingdom.
- College of Science, Engineering and Technology, Institute for Nanotechnology and Water Sustainability, University of South Africa, Johannesburg, South Africa.
Zitieren
APA
Singh, S., Samson, R., & Hassard, F. (2025). Phage therapy for environmental biotechnology applications. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1621103
Vancouver
Singh S, Samson R, Hassard F. Phage therapy for environmental biotechnology applications. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1621103
BibTeX
@article{Singh2025,
author = {Singh, Suniti and Samson, Rachel and Hassard, Francis},
title = {Phage therapy for environmental biotechnology applications},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1621103}
}
EUVIMED